Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Dambra R"'
Autor:
Basu R; Materials and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA., Dambra R; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Jiang D; Materials and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA., Schätzlein SA; Therapeutic Virus Development Group, Virus Therapeutic Center, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Njiyang S; Therapeutic Virus Development Group, Virus Therapeutic Center, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Ashour J; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Chiramel AI; Therapeutic Virus Development Group, Virus Therapeutic Center, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Vigil A; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Papov VV Jr; Materials and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2024 Aug 06; Vol. 12 (8), pp. e0365123. Date of Electronic Publication: 2024 Jun 25.
Autor:
Dambra R; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.; Drexel University School of Biomedical Engineering, Science and Health Systems, Philadelphia, PA 19104, USA., Matter A; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Graca K; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Akhand SS; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Mehta S; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Bell-Cohn A; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Swenson JM; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Abid S; Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Xin D; Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Lewis C; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Coyle L; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Wang M; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Bunosso K; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Maugiri M; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Ruiz R; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Cirillo CM; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Fogal B; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Grimaldi C; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Vigil A; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Wood C; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Ashour J; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2022 Dec 28; Vol. 28, pp. 190-207. Date of Electronic Publication: 2022 Dec 28 (Print Publication: 2023).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Klein D; Janssen Pharmaceuticals, Spring House, PA, USA. Electronic address: dklein30@its.jnj.com., Goldberg S; Janssen Pharmaceuticals, Spring House, PA, USA., Theile CS; Alnylam, Cambridge, MA, USA., Dambra R; Janssen Pharmaceuticals, Spring House, PA, USA., Haskell K; Janssen Pharmaceuticals, Spring House, PA, USA., Kuhar E; Janssen Pharmaceuticals, Spring House, PA, USA., Lin T; Janssen Pharmaceuticals, Spring House, PA, USA., Parmar R; Alnylam, Cambridge, MA, USA., Manoharan M; Alnylam, Cambridge, MA, USA., Richter M; Janssen Pharmaceuticals, Spring House, PA, USA., Wu M; Janssen Pharmaceuticals, Spring House, PA, USA., Mendrola Zarazowski J; Janssen Pharmaceuticals, Spring House, PA, USA., Jadhav V; Alnylam, Cambridge, MA, USA., Maier MA; Alnylam, Cambridge, MA, USA., Sepp-Lorenzino L; Alnylam, Cambridge, MA, USA., O'Neil K; Janssen Pharmaceuticals, Spring House, PA, USA. Electronic address: koneil@arobiotx.com., Dudkin V; Janssen Pharmaceuticals, Spring House, PA, USA.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Jun 02; Vol. 29 (6), pp. 2053-2066. Date of Electronic Publication: 2021 Feb 15.
Autor:
André, M., Baudin, E., Beltran Palomo, P., Dambra, R., Delente, M., Gaggero, Tomaso, Haimov, E., Hallander, J., Houbeni, M., Ianniello, S., Jimenez Caballero, S., Pirovsky, C. h., Rantanen, A., Rizzuto, Enrico, Turan, O.
Transports are well known to be major contributors to noise pollution. Noise and vibrations (N&V) abatement naturally appears as an important objective for the greening of surface transports. The SILENV project is a response to this requirement for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e09a1814077a07f2253fc9576a380be4
http://hdl.handle.net/11588/720463
http://hdl.handle.net/11588/720463
Autor:
Nappi, Francesco1 (AUTHOR) francesconappi2@gmail.com
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3630. 36p.
Publikováno v:
Vaccines; Aug2024, Vol. 12 Issue 8, p867, 21p